Sweden: Lembrer to join Oncopeptides as CFO

Holger Lembrer, incoming CFO at Oncopeptides

Another top level appointment has been announced at Nasdaq Stockholm listed Oncopeptides, a biotech company focused on research and development of therapies for difficult-to-treat hematological diseases. Following on from news that Monica Shaw had joined the company as CEO comes the appointment of Holger Lembrer as CFO. He is replacing interim CFO Annika Muskantor who…

You must be a HMI Subscriber to view this content.

Subscribe Now »